Further studies have documented that IGF-1/IGF-1R-mediated enhanced pancreatic carcinoma proliferation and invasiveness requires an interaction between IGF-1R and the hepatocyte growth receptor c-Met [26]. This evidence concerns the gene IGF1 and exocrine pancreatic carcinoma.